Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.

Address

1350 Old Bayshore Highway

Suite 400

Website

https://www.inva.com

Classification

Sector

Healthcare

Industry Group

Biotechnology

Industry

Biotechnology

Key Executives

Mr. Jules Haimovitz

Director

Dr. Odysseas D. Kostas, M.D.

Director

Dr. Sapna Srivastava, PhD

Director

Dr. Sarah J. Schlesinger, M.D.

Director

Mr. Mark DiPaolo, Esq.

Director

Ms. Marianne Zhen

Chief Accounting Officer

Mr. Pavel Raifeld

CEO

Mr. Stephen Basso

CFO

Ownership

Institution Holdings

BlackRock Inc

10,352,073 (16.373%)

Sarissa Capital Management LP

7,277,000 (11.509%)

BlackRock Fund Advisors

6,971,384 (11.026%)

Vanguard Group Inc

6,712,443 (10.616%)

Putnam Investments LLC

6,270,413 (9.917%)

Putnam Investment Management, LLC

6,229,047 (9.852%)

Dimensional Fund Advisors, Inc.

4,516,999 (7.144%)

Renaissance Technologies Corp

4,144,447 (6.555%)

Dimensional Fund Advisors LP

3,408,848 (5.391%)

Westfield Capital Management Company, LP

2,614,127 (4.134%)

Funds Holdings

iShares Core S&P Small-Cap ETF

3,830,668 (5.977%)

Pacer US Small Cap Cash Cows 100 ETF

2,277,391 (3.554%)

Vanguard Small Cap Index

1,472,989 (2.298%)

iShares Russell 2000 ETF

1,453,567 (2.268%)

Westfield Capital Mgt Co Sm-Cap Gr Eq

1,118,006 (1.745%)

Harbor Small Cap Growth Fund

1,118,006 (1.745%)

Vanguard Small Cap Value Index Fund

1,011,540 (1.578%)

Vanguard Institutional Extnd Mkt Idx Tr

847,917 (1.323%)

Fidelity Small Cap Index Fund

585,478 (0.914%)

iShares Russell 2000 Value ETF

529,295 (0.826%)

Details

Overview

Company Info

Key Ratios

Income

Balance Sheet

Cash Flow

Bubble

Make Smart Investment Choices